Bayer HealthCare AG acquires the German biotech company Direvo Biotech AG, Cologne for a total consideration of Euro 210 million. With the acquisition of the biotech company specialized in protein engineering, Bayer strengthens the research competence in biologicals of its pharmaceutical division Bayer Schering Pharma.
The details can be read here.
No comments:
Post a Comment